Translational medicine: the discovery of bridging biomarkers using pharmacogenomics

Author: Mendrick, Donna L

Source: Pharmacogenomics, Volume 7, Number 6, September 2006 , pp. 943-947(5)

Price: $63.00 plus tax (Refund Policy)

Keywords: biomarker; bridging biomarker; critical path initiative; FETUB; gene ontology; Kim-1; pharmacogenomics; pharmacogenomics guidance document; relational database; toxicogenomics

Document Type: Opinion

DOI: http://dx.doi.org/10.2217/14622416.7.6.943

Affiliations: 1: Gene Logic Inc., 610 Professional Drive Gaithersburg, MA 20879, USA., Email: dmendrick@genelogic.com

Publication date: 2006-09-01

More about this publication?

Pharmacogenomics provides the community with an essential resource for keeping abreast of the latest developments in new pharmacogenomic initiatives, emerging technologies for accessing genomic information and the development of novel diagnostic products and strategies.
Editorial Board
Information for Authors
Submit a Paper
Subscribe to this Title
Information for Advertisers
Terms & Conditions
Information for Librarians
E-Access Trials
ingentaconnect is not responsible for the content or availability of external websites